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Fibulin-4 and -5 are extracellular glycoproteins with essential
non-compensatory roles in elastic fiber assembly. We have
determined how they interact with tropoelastin, lysyl oxidase,
and fibrillin-1, thereby revealing how they differentially regu-
late assembly. Strong binding between fibulin-4 and lysyl oxi-
dase enhanced the interaction of fibulin-4 with tropoelastin,
forming ternary complexes thatmaydirect elastin cross-linking.
In contrast, fibulin-5 did not bind lysyl oxidase strongly but
bound tropoelastin in terminal and central regions and could
concurrently bind fibulin-4. Both fibulins differentially bound
N-terminal fibrillin-1, which strongly inhibited their binding
to lysyl oxidase and tropoelastin. Knockdown experiments
revealed that fibulin-5 controlled elastin deposition onmicrofi-
brils, although fibulin-4 can also bind fibrillin-1. These experi-
ments provide a molecular account of the distinct roles of fibu-
lin-4 and -5 in elastic fiber assembly and how they act in concert
to chaperone cross-linked elastin onto microfibrils.
Fibulins are a family of extracellular glycoproteins containing
contiguous calcium-binding epidermal growth factor-like do-
mains (cbEGFs)3 and a characteristic C-terminal fibulin (FC)
domain (1–3). Recent studies have revealed that fibulin-4 and
-5 are both essential for elastic fiber formation (4–7). Fibulin-4
is widely expressed from early embryogenesis and is necessary
for normal vascular, lung, and skin development, since mice
that lack fibulin-4 do not form elastic fibers and die perinatally
(5). Furthermore, mice with reduced fibulin-4 expression
develop aneurysms (8). Fibulin-5 is abundant in the aorta and
large arteries during embryogenesis and following vascular
injury (9, 10). Lack of fibulin-5 causes a less severe phenotype,
with viable homozygous mice, but the elastic fibers in skin,
lungs, and aorta are irregular and fragmented (6, 7), and there is
altered vascular remodeling (11). Thesemicemodels also high-
light that fibulin-4 and -5 have non-compensatory roles in elas-
tic fiber formation.Mutations in bothmolecules can cause cutis
laxa, a heritable disorder associated with elastic fiber degener-
ation leading to sagging skin, vascular tortuosity, and emphyse-
matous lungs (12–15). A third isoform, fibulin-3, may play a
minor role in elastic fiber formation, since its deficiency dis-
rupts elastic fibers in Bruch’s membrane of the eye (16) and
vaginal tissues (17).
Elastic fiber formation is a complex multistep process (18–
20). Initial pericellular microassembly of tropoelastin, which
may involve the 67-kDa elastin-binding protein receptor, gen-
erates elastin globules that are stabilized by desmosine cross-
links catalyzed mainly by lysyl oxidase (LOX) but also by
LOXL1 (LOX-like 1). These globules are deposited on a fibrillin
microfibril template, where they coalesce and undergo further
cross-linking to form the elastin core ofmature fibers. The abil-
ity of fibulin-4 and -5 to bind tropoelastin and fibrillin-1, the
major structural component of microfibrils, supports a model
in which these fibulins direct elastin deposition on microfibrils
(4–7, 21–25). This model does not delineate the uniquemolec-
ular contributions of fibulin-4 and -5 to elastic fiber formation,
but some molecular differences have emerged. Tropoelastin
was bound more strongly by fibulin-5 than by fibulin-4,
whereas fibulin-5 was at the microfibril-elastin interface, but
perichondrial fibulin-4 localized mainly to microfibrils (4).
Fibulin-4 null mice offer tantalizing clues to how fibulin-4
contributes to elastic fiber formation (5). They had dramatically
reduced (94%) desmosine cross-links despite no change in elas-
tin or LOX expression levels, and electron-dense rodlike struc-
tures were prominent within elastin aggregates. Morphologi-
cally similar structures seen after chemically inhibiting LOX
were previously identified as glycosaminoglycans, which can
bind charged free -amino groups on lysines in tropoelastin
(26). However, fibulin-4/ mice showed 20% increase in
desmosine (5). LOX-null mice have phenotypic features similar
to those of fibulin-4 null mice, dying perinatally with 60%
reduced desmosine cross-links andmajor abnormalities in vas-
cular and other elastic tissues (27, 28). In contrast, LOXL1-null
mice are viable but have reduced desmosine (29), whereas fibu-
lin-5 null mice have a 16% reduction in desmosine cross-links
and survive well into adulthood (7). Detection of the LOXL1
pro-domain in fibulin-5 null mice skin but not wild-type skin
implicates fibulin-5 in activation of LOXL1 (30).
We and others have shown that fibrillin-1 and the microfi-
brillar protein MAGP-1 can both directly bind tropoelastin
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(31–34). However, the fibulin-null mice show that the fibril-
lin-1 interaction with tropoelastin is insufficient to support
elastic fiber formation in vivo. Fibulin-5 has been reported to
facilitate tropoelastin binding to the N-terminal half of fibril-
lin-1 (21). A study of elastin polypeptide self-assembly through
coacervation andmaturation phases showed that, although the
N-terminal half of fibrillin-1 increased maturation velocity and
droplet clustering, fibulin-4 and -5 both slowedmaturation and
limited globule growth (35). These studies imply that fibulins
and fibrillin-1 act together to regulate elastin accretion on
microfibrils.
To gain further insights into the contributions of fibulin-4
and -5 to elastic fiber formation, we have delineated how they
interact with tropoelastin, LOX, and fibrillin-1. Novel findings
are that fibulin-4 directly binds LOX, and this interaction
enhances fibulin-4 binding to tropoelastin, thus forming a ter-
nary complex that may be critical for elastin cross-linking.
Fibulin-5 can concurrently bind fibulin-4 and tropoelastin, but
the interaction of both fibulins with fibrillin-1 strongly inhibits
their binding to tropoelastin. These interactions indicate the
molecular basis of how fibulins act as chaperones for deposition
of elastin onto microfibrils. Our study thus provides a molecu-
lar account of the differential roles of fibulins-4 and -5 in elastic
fiber formation.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant Proteins—All
human elastic fiber proteins were expressed with an N-ter-
minal His6 tag, using the mammalian expression vector
pCEP-His and 293-EBNA cells, and purified using nickel
affinity chromatography as described (22, 33, 36–41) (Fig. 1
and supplemental Fig. S1).
Full-length human fibulin-4 (residues 26–418) was desig-
nated F4 (Fig. 1A). A truncated version of full-length fibulin-4
(designated tF4) was expressed by one culture of transfected
cells; analysis bymass spectrometry revealed the absence of the
C-terminal sequence (53 residues, comprising the FC domain
and 6 residues of the preceding linker region) (supplemental
Fig. S2A). We also expressed the N-terminal four domains of
fibulin-4 (residues 26–217; designated nF4) and the central
cbEGFs 2–6 (residues 98–303; designated eF4). The C-termi-
nal four domains did not express efficiently.
Full-length human fibulin-5 (residues 42–448) was desig-
nated F5 (Fig. 1A). Full-length fibulin-5 incorporating two cutis
laxa mutations, C217R and S227P (F5C217R and F5S227P) (13),
were expressed together with five overlapping domain pairs of
fibulin-5 (residues 42–167 (F5-E12), 127–206 (F5-E23),
207–287 (F5-E45), 247–333 (F5-E56), and 288–448 (F5-
E6FC)) (Fig. 1A). A sixth domain pair (F5-E34) did not
express efficiently.
Human fibrillin-1 fragments generated for this study were
PF1, PF2, PF4, PF5, PF7, PF8, PF9, PF11, PF12, and PF13 (33,
37–41) (Fig. 1B). We also generated PF1 variants with the
Marfanmutation R62C, T101A, or S115C. In addition, we used
our panel of N-terminal deletion mutants: PF1 encoded by
exons 1–11 (residues 31–489), Ex1–11 encoded by residues
45–489), Ex3–11 encoded by exons 3–11 (residues 81–489),
Ex4–11 encoded by exons 4–11 (residues 115–489), Ex5–11
encoded by exons 5–11 (residues 147–489), Ex6–11 encoded
by exons 6–11 (residues 179–489), Ex7–11 encoded by exons
7–11 (residues 246–489), and a three-domain fragment Ex5–7
encoded by exons 5–7 (residues 147–287) (39). Cells trans-
fected with full-length fibrillin-1 expressed a large fragment
comprising the N-terminal two-thirds of the molecule (250
kDa; designated tFib-1) (Fig. 1B and supplemental Fig. S1B);
mass spectrometry indicated that the cleavage site was after the
domain encoded by exon 43 (supplemental Fig. S2B). Human
full-length LOX (Fig. 1C) was expressed and purified, as out-
lined above (supplementary Fig. S1C). Recombinant human
tropoelastin lacking domain 26A was a generous gift from Dr.
A. S. Weiss (Sydney, Australia) (42, 43).
Purification and Biophysical Characterization of Recombi-
nant Proteins—After nickel affinity chromatography, mono-
meric recombinant proteins were isolated by Superdex S200
10/300 GL size fractionation (GE Healthcare) in 10 mMHepes-
buffered saline, pH 7.4, containing 150 mM NaCl (HBS), using
an AKTA purifier system. cDNA sequencing, SDS-PAGE,
Western blotting with anti-His antibody (Sigma), and mass
spectrometry confirmed the correct products (Fig. 1 and sup-
plemental Figs. S1 and S2; data not shown). All molecules with
NX(S/T) motifs were N-glycosylated, as determined by treat-
ment with peptide:N-glycanase F (New England Biolabs). In all
cases, the monomer fractions from S200 chromatography were
equilibrated in HBS containing 0.5 mM CaCl2 (HBSCa) for
subsequent binding assays.
Monomers of fibulin-4 (F4, nF4, and tF4) and fibulin-5 (F5,
F5S227P, and domain pairs F5-E12, F5-E23, F5-E45,
F5-E56, and F5-E6FC) that had been isolated by Superdex 200
gel filtration in HBS, were analyzed by multiangle laser light
scattering (MALLS) in HBS or HBSCa. Samples eluting from
the column passed through aWyatt EOS 18-angle light scatter-
ing detector fitted with a 688-nm laser and an Optilab r-EX
refractometer. The solute molecular mass was determined
using in-line MALLS attached to quasielastic light scattering
and a differential refractometer (Wyatt Technology Corp.)
(Table 1 and supplemental Fig. S3). Themonomers hadmolec-
ular masses that corresponded well with SDS-PAGE analysis
(see supplemental Fig. S1).
LOX monomers were isolated on a Superdex 200 gel filtra-
tion column in 10mMTris, pH 7.4, with 150mMNaCl contain-
ing 1mMCaCl2 (TBSCa). MALLS analysis revealed that LOX
was monomeric with a molecular mass of 47.5 kDa, compared
with 50 kDa by SDS-PAGE (supplemental Fig. S1). Analysis of
LOX by circular dichroism revealed 5% -helix, 31% -strand,
and 13% -turn. Analysis of LOX by analytical ultracentrifuga-
tion revealed a molecular mass of 48.9 kDa, measured S20,w of
2.2, calculated hydrodynamic radius of 5.41, and frictional ratio
of 2.25.
Single Particle Averaging of Fibulin-4—Purified F4 mono-
mers in 10 mM Tris, pH 7.4, containing 500 mM NaCl (TBS)
were adsorbed onto glow-discharged carbon-coated 400-mesh
copper grids, negatively stained with 2% uranyl acetate, and
analyzed by single particle averaging, as described (Fig. 2) (37).
Briefly, samples were observed at 52,000 magnification using
an FEI Tecnai 12 transmission electron microscope operating
at 120 kV with a LaB6 filament, and images were recorded by a
Fibulin-4 and -5 Regulate Elastic Fiber Assembly
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CCD camera (TVIPS TemCam, 2048 2048 resolution) using
low dose (10e/Å2) at defocus values of 2 m. The pixel size
was 1.9 Å. Images were analyzed using electron microscopy
analysis (EMAN) (44) for all data processing. The data set con-
tained 3538 particles, which were aligned and classified by ref-
erence-free methods. A preliminary three-dimensional struc-
ture was calculated by averaging classes that represented
distinct views of the sample. Fourier common lines were
applied to determine the relative orientation of these classes.
The preliminary structurewas subsequently refined by iterative
(eight times) projection matching. Each refinement was exam-
ined by the convergence of the Fourier shell correlation coeffi-
cient. Final resolution of the F4 reconstructionwas20Åusing
the Fourier shell correlation  0.5 criterion.
BIAcore Analysis of Interactions with Tropoelastin and LOX—
For kinetic binding studies by surface plasmon resonance, a
BIAcore biosensor was used (BIAcore 3000; GE Healthcare).
Tropoelastin or LOX was immobilized onto CM5 sensor chips
by amine coupling using 1-ethyl-3(3-dimethylaminopropyl)-
carbodiimide hydrochloride,N-hydroxysuccinimide, and etha-
nolamine-HCl, as described (33, 39). All binding experiments
were performed in HBSCa. LOX, fibulin-4, or fibulin-5 was
injected at concentration ranges of 2–10 g/ml for F4 or
0.4–10 g/ml for F5 or LOX for 3–5 min at a flow rate of 30
l/min. Curves were fitted using a 1:1 Langmuir association/
dissociation model (BIAevaluation 4.1; GE Healthcare). This
model was found to fit the tropoelastin-fibulin-5 and LOX-
fibulin-4 data, with low 2 values. 2 values are a standard sta-
tisticalmeasure of the closeness of fit (mean square of the signal
noise). Each binding interaction was performed at least twice,
with one concentration in duplicate each time. Some BIAcore
experiments investigated potential inhibitory effects of a given
elastic fiber protein on binding of a second protein to immobi-
lized tropoelastin or LOX.Kinetic analysiswas performedusing
ligand protein (F5 at 100 nM; F4 at 200 nM; LOX at 200 nM)
preincubated with a 0.01 nM to 3 M concentration of the
potential inhibitor protein or with a non-binding control fibril-
lin-1 fragment PF12, in HBSCa, as described (38). Inhibition
curves were plotted using the response value of each normal-
ized curve at the end of the association period.
Solid Phase Binding and Inhibition Assays—Because fibril-
lin-1 and the two fibulins when immobilized to BIAcore CM5
chips do not interact sufficiently with other proteins and to
investigate further the interactions between LOX and tro-
poelastin and between fibrillin-1 and LOX, solid phase assays
were utilized, as described (22, 33, 39). Soluble ligands were
biotinylated using sulfosuccinimidyl 2-(biotinamido)-ethyl-
1,3-dithiopropionate (Pierce). Flat-bottomed microtiter plates
were coated with tropoelastin, LOX, fibulin-4 or -5, or N-ter-
minal fibrillin-1 fragments, at 100 nM in 10 mM Tris, pH 7.4,
containing 150 mM NaCl and 1 mM CaCl2 (TBSCa) buffer,
overnight at 4 °C. Nonspecific binding sites were blocked with
TBSCa containing 5% bovine serum albumin at room tem-
perature for at least 2 h. The plates were washed three times
with TBSCa, 0.1% bovine serum albumin and incubated with
100 nM biotinylated ligand. Control wells with only soluble bio-
tinylated ligand were included in all experiments. After a fur-
ther threewashes, plateswere incubatedwith a 1:500 dilution of
extravidin peroxidase conjugate at room temperature for 20
min. Bound protein was quantified after four more washes by a
colorimetric assay using 40 mM 2,2-azino-bis(3-ethyl-benz-
thiazoline-6-sulfonic acid) solution (Sigma) for 10–20 min at
room temperature. Plates were read at a wavelength of 405 nm.
Wells were washed four times, and the color was developed.
Any nonspecific binding was detected by blocking wells before
incubation with bovine serum albumin only. All experiments
were performed in triplicate, and all assays were repeated at
least twice. In some experiments, the effects of inhibition of
binding by other elastic fiber molecules or by heparin (3 kDa;
Sigma) were conducted with increasing concentrations of
potential inhibitors preincubated with soluble ligand. For
kinetic and statistical analysis, GraphPad Prism was used to
obtain dissociation constants (Kd) (33, 40), and unpaired t tests
were used to calculate significance. Results were statistically
significant when the p value is 0.05 (*, p  0.05; **, p  0.01;
***, p  0.001).
Knockdown and Induced Expression of Elastic Fiber Proteins—
Reverse transcription-PCR analysis of the expression of fibu-
lin-4 and -5 was conducted on ARPE-19 cells (supplemental
Fig. S5A). Validated siRNAs (pools of three target-specific
siRNAs; Santa Cruz Biotechnology, Inc. (Santa Cruz, CA);
sc-75017 and sc-43121) were used to knock down human fibu-
lin-4 in the ARPE-19 retinal pigmented epithelial cell line, with
scrambled siRNA and no-siRNA controls. Cells (5  105 cells)
were transfected with 200 nM siRNAs for fibulin-4 or with
scrambled siRNAs (200 nM) by electroporation using cell-spe-
cific Nucleofector reagent (Amaxa). Parallel siRNA experi-
ments were conducted on ARPE-19 cells that had been trans-
duced with the pQCXIP retroviral vector (Clontech) for
constitutive expression of human tropoelastin (supplemental
Fig. S5B) and on transduced control ARPE-19 cells. Control
and siRNA-transfected cells were plated at confluence and
cultured for up to 7 days in Dulbecco’s minimum essential
medium supplemented with 10% fetal calf serum, penicillin,
and streptomycin. Knockdown efficacy was confirmed to be
70% at the mRNA level by quantitative PCR (supplemental
Fig. S5A) and was also reduced at the protein level by West-
ern blotting, using an anti-fibulin-4-specific polyclonal anti-
serum raised to nF4 (1:1000 dilution). Anti-fibulin-5 anti-
body (1 g/ml monoclonal antibody 3095; R&D Systems)
was also used (not shown). Using the pSuper.retro.neogfp
(pSR) vector (Oligoengine), stable knockdown of fibulin-5
was achieved in RFL-6 rat fetal lung fibroblasts (13) and con-
firmed at mRNA (supplemental Fig. S5C) and protein levels
(not shown).
Light and Electron Microscopy of Cell Layers—Cell layers
from fibulin-5 shRNA and control cultures were imaged by
light microscopy after Miller’s staining. Cells (8  104 cells/
coverslip in 24-well plates) were cultured for 8–12 days before
being fixed with 4% paraformaldehyde for 20 min. Coverslips
were washed in phosphate-buffered saline before being oxi-
dized with acidified potassium permanganate. Samples were
washed in distilled H2O, decolorized with 1% oxalic acid,
washed in 95% ethanol andH2O, and stained withMiller’s stain
(GCC Diagnostics) for 3 h. Samples were washed in 95% etha-
Fibulin-4 and -5 Regulate Elastic Fiber Assembly
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nol and distilled H2O before being counterstained with Van
Gieson stain (GCC Diagnostics). Prior to mounting, samples
were washed in 95% ethanol and distilled H2O.
Cells grown on Aclar film were fixed with 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer, postfixed with 1% osmium
tetroxide for 1 h, and treated with 1% tannic acid for 1 h and
with 1% uranyl acetate for 1 h.
They were dehydrated with alco-
hol series and embedded in TAAB
LV resin. Ultrathin en face sec-
tions were cut at a Reichert
Ultracut S Ultramicrotome and
contrasted with lead citrate. Sec-
tions were observed with an FEI
Tecnai Biotwin 12 microscope at
100 kV accelerating velocity.
Desmosine Cross-link Assay—Ex-
periments were conducted to ana-
lyze desmosine cross-link forma-
tion, using ARPE-19 cells. We used
untreated control ARPE-19 cells,
ARPE-19 cells stably expressing
transfected tropoelastin (supple-
mental Fig. S5), and ARPE-19 cells
cultured in the presence of supple-
mented exogenous human tro-
poelastin (10g/ml) (45). Cellswere
subjected to siRNA knockdown of
fibulin-4, and after culture for up to
7 days, cell layers were scraped into
tubes in 100 l of distilled H2O.
ARPE-19 cell layers were kindly
analyzed for elastin desmosine
cross-links by Dr. Barry Starcher.
RESULTS
We generated and characterized
recombinant human fibulin-4 and
-5, fibrillin-1, andLOX (Fig. 1, Table
1, and supplemental Figs. S1–S3).
These molecules were used to ana-
lyze the interactions of both fibulins
with tropoelastin, LOX, and fibril-
lin-1 and to determine how fibu-
lin-4 and -5 differentially regulate
elastin cross-linking and deposition.
After nickel chromatography,
monomers of full-length human
fibulin-4 (F4), theN-terminal half of
fibulin-4 (nF4), the central five
cbEGF-like domains (eF4), and a
C-terminally truncated fragment
(tF4) were isolated by Superdex
S200 size fractionation in HBS.
SDS-PAGE analysis indicated mo-
lecular masses for F4 of 52 kDa, for
nF4 of 40 kDa, and for eF4 of 36 kDa
(supplemental Fig. S1A). The trun-
cated molecule tF4 formed disulfide-bonded dimers of 75 kDa.
MALLS analysis in HBS confirmed that F4 in solution was
monomeric in the absence of CaCl2, with a molecular mass of
52 kDa (Table 1 and supplemental Fig. S3). In the presence of
CaCl2, F4 contained some monomers but was predominantly
dimeric. Electron microscopy and single particle averaging
FIGURE 1. A, recombinant human fibulin-4 and -5. Domain structures of full-length fibulin-4 (F4), C-terminally
truncated fibulin-4 (tF4), the N-terminal half of fibulin-4 (nF4), and the five central cbEGFs (eF4) are shown, with
a key of the domains and N-glycosylation sites. Also shown are the domain structures of full-length fibulin-5
(F5) with the sites of the two cutis laxa mutations (F5C217R and F5S227P) and domain pair fragments. Details of
the domains are given (see key). For SDS-PAGE analysis of recombinant fibulins, see supplemental Fig. S1A.
B, recombinant human fibrillin-1. Domain structures of full-length fibrillin-1, a C-terminally truncated two-third
fragment of fibrillin-1 (tFib-1), overlapping fragments, and N-terminal deletion fragments are shown, with a key
of the domains and N-glycosylation sites. All fragments have been described (39, 55) except for tFib-1 (for mass
spectrometry of tFib-1, see supplemental Fig. S2B). Details of the domains are given (see key), and the colors
indicate overlapping recombinant fragments. For SDS-PAGE analysis of recombinant tFib-1, see supplemental
Fig. S1B. C, recombinant human LOX. The molecular arrangement of full-length human LOX is shown. BMP-1,
position of the bone morphogenetic protein-1 cleavage site. For SDS-PAGE analysis of recombinant LOX, see
supplemental Fig. S1C. EGF, epidermal growth factor.
Fibulin-4 and -5 Regulate Elastic Fiber Assembly
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revealed that F4 has an elongated shape (13–14-nm length)
with 6–7-nm diameter and a small globular end (Fig. 2).
After nickel chromatography, monomers of full-length fibu-
lin-5 (F5) had a molecular mass of 53 kDa by SDS-PAGE (sup-
plemental Fig. S1A). MALLS analysis in HBS indicated a solu-
tionmolecularmass for F5 of 51 kDa and for themutant F5S227P
of 52 kDa (Table 1 and supplemental Fig. S3). Solution molec-
ular masses for each monomeric fibulin-5 domain pair frag-
ment in HBS by MALLS range from 13 to 24 kDa (Table 1).
Recombinant fibulin-5 had a similar structure to fibulin-4 by
single particle averaging.4
Defining Molecular Interactions of Fibulin-4 and -5
Monomeric molecules and fragments were equilibrated in
HBSCa for interaction studies.
Tropoelastin Binds Fibulin-5 More Strongly than Fibulin-4—
Tropoelastin was reported to bind to murine fibulin-4, using
solid phase binding and co-immunoprecipitation (5). Here,
BIAcore analysis confirmed that F4 bound tropoelastin (Fig.
3A). The F4 interaction with tropoelastin indicated more rapid
dissociation kinetics than F5 (see below), but binding affinities
could not be determined using the 1:1 Langmuir association/
dissociationmodel (BIAevaluation version 4.1; GEHealthcare).
Solid phase binding assays indicated that soluble F4 bound
immobilized tropoelastin with a KD of 131  8 nM but showed
virtually no binding to the fibulin-4 fragments nF4, eF4, or tF4
(Fig. 3B) (data not shown). Thus, fibulin-4 binds tropoelastin
with moderate affinity, with the binding site at or adjacent to
the fibulin-4 FC domain.
Tropoelastin was reported to bind fibulin-5 in N- and C-ter-
minal regions (24, 25). Here, BIAcore analysis revealed that F5
bound tropoelastin strongly (KD  64  40 nM) (Table 2 and
Fig. 3A). Full-length cutis laxa mutants F5C217R and F5S227P
(mutations in cbEGF4) both showedmarkedly reduced binding
affinities for tropoelastin, with rapid dissociation kinetics
(Table 2 and Fig. 3A). In solid phase binding assays, soluble
fibulin-5 domain pair fragments (F5-E12, F5-E45, and
F5-E6FC) bound immobilized tropoelastin, with the strongest
binding by F5-E6FC (Fig. 3C; for binding curves, see supple-
4 Jones, R. P. O., Wang, M.-C., Jowitt, T. A., Ridley, C., Mellody, K. T., Howard, M.,
Wang, T., Bishop, P. N., Lotery, A. J., Kielty, C. M., Baldock, C., and Trump, D.
(July 17, 2009) J. Biol. Chem. 10.1074/jbc.M109.011627.
FIGURE 2. Electron microscopy and single particle averaging of full-
length fibulin-4. F4 was equilibrated in TBS prior to adsorption onto carbon-
coated grids. i, representative class averages from a data set of 3538 fibulin-4
molecules. ii, a three-dimensional reconstruction of fibulin-4 was generated
using angular reconstitution. For i and ii, the box size is 19  19 nm. The data
indicate that the length of fibulin-4 is 13–14 nm with a central bend and a
globular end-domain. This result extends previous rotary shadowing studies
of fibulin-4 molecules, which indicated short rods of 10 –20 nm in length and
an end globule (4, 51).
TABLE 1
MALLS analysis of fibulin-4 and -5
Fibulin-4 and -5 were analyzed by MALLS to obtain details of their molecular
masses in solution (for domain structures, see Fig. 1A). Without added CaCl2 (HBS
buffer), F4 and nF4 were monomeric. In the presence of 0.5 mM CaCl2 (HBSCa
buffer), apparent dimers predominated, and some larger aggregates were also
detected (data not shown). Similarly, F5 was monomeric in HBS (below) but dimer-
ized in HBSCa (data not shown).4 Fibulin-5 mutant F5S227P and fibulin-5 domain
pairs were also monomeric in HBS. Calculated molecular masses from primary
sequences (without carbohydrate) and SDS-PAGE-determined molecular masses
are also shown.
Molecule (buffer)
MALLS-
measured
molecular mass
SDS-PAGE-
measured
molecular mass
Calculated
molecular
mass
kDa kDa kDa
F4 (HBS) monomer 52 52 49
nF4 (HBS) monomer 30 40 27
F4 (HBSCa) “dimer” 94
F4 (HBSCa) monomer 56
nF4 (HBSCa) “dimer” 60
nF4 (HBSCa) monomer 31
F5 (HBS) monomer 51 53 50
F5-S227P (HBS) monomer 52
F5-E12 (HBS) monomer 20 25 14
F5-E23 (HBS) monomer 13 15 9
F5-E45 (HBS) monomer 13 15 9
F5-E56 (HBS) monomer 16 18 10
F5-E6FC (HBS) monomer 24 30 19
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mental Fig. S4A). The tropoelastin interaction with F5-E6FC
was partially calcium-dependent (not shown). Binding of the
full-length mutants and fragment F5-E45 to tropoelastin
indicate that cbEGF4 contributes to F5-tropoelastin interac-
tions. Thus, fibulin-5 binds tropoelastin strongly, with binding
sites in N- and C-terminal and central cbEGF array regions.
LOX Binds Strongly to Fibulin-4 but Weakly to Fibulin-5—
LOX, the major cross-linking enzyme of elastic fibers, is tar-
geted to elastic fibers through its pro-domain (46). Using BIA-
core, we examined whether full-length human LOX (see Fig.
1C) interacts with fibulin-4 and -5. F4 bound to immobilized
LOX with high affinity (KD  33  3 nM) (Table 2 and Fig. 4A).
nF4 also bound LOX strongly with a KD of 14  6 nM (Table 2
and Fig. 4A), but tF4 bound only weakly (Fig. 4A), and the cen-
tral eF4 fragment did not bind LOX (not shown). Thus, we have
identified a strong binding site for LOX within the N-terminal
half of fibulin-4. Using BIAcore, we also confirmed binding of
LOX to immobilized F4 (Fig. 4A).
BIAcore analysis did not detect any F5 binding to LOX.How-
ever, solid phase binding assays did detect relatively weak inter-
actions between soluble LOX and immobilized F5 (KD  304
69 nM) (Fig. 4B) and between soluble LOX and immobilized
fibulin-5 domain pairs F5-E12, F5-E23, F5-E45, and
F5-E6FC (not shown). Thus, fibulin-5 does not contain a strong
specific binding site for LOX.
Fibulin-4 Binds Fibulin-5—Solid phase binding assays re-
vealed that soluble F4 can bind immobilized F5 with moderate
affinity (KD  161  10 nM) (Fig. 4C). This novel interaction
was with the C-terminal half of fibulin-4, since soluble F4 (100
nM) bound, but soluble nF4 (100 nM) showed virtually no bind-
ing to immobilized F5 (Fig. 4C). Similarly, BIAcore revealed
that soluble F5 binds immobilized F4, with aKD of 182 nM (
2

1.27) (Fig. 4A). However, none of the fibulin-5 domain pair
fragments showed strong binding to immobilized F4 (not
shown). This novel interaction between fibulinsmay contribute
to regulating elastin globule formation and deposition.
N-terminal Fibrillin-1 Binds Differentially to Fibulin-4 and
-5—We and others have reported that the N-terminal half of
fibrillin-1 binds to fibulin-4 and -5 (21, 22), and the third EGF-
like domain and first hybrid domain of fibrillin-1 are implicated
(21). Here, solid phase and BIAcore binding assays provided
detailed analysis of the binding specificities of fibulin-4 and -5
to a panel of fibrillin-1 fragments (39). Our data show that these
fibulins differentially interact with N-terminal fibrillin-1.
BIAcore analysis showed that soluble PF1 bound strongly to
immobilized F4with steady-state affinity of 74 5 nM (Fig. 4A),
but virtually no binding to overlapping PF2 was detected. How-
ever, using solid phase assays, soluble F4 bound strongly to the
N-terminal fibrillin-1 fragment PF1 (KD  134 17 nM) and to
PF2 (KD 194 26nM), which does not contain the first hybrid
motif (Fig. 5A); both fragments contain the first TB module,
proline-rich region, and following EGF-like domain (see Fig.
1B) (39). F4 also bound strongly to three PF1 deletion fragments
(Ex1–11, Ex3–11, and Ex5–11) andmoderately to Ex6–11 (Fig.
5A). However, there was only low F4 binding to fibrillin-1 frag-
ment PF4, which contains the first hybrid motif, and virtually
no binding to fibrillin-1 fragment Ex5–7, which comprises the
first hybrid motif and flanking domains, or to fibrillin-1 frag-
ment Ex7–11, which comprises five domains downstream of
the first hybridmotif (Fig. 5A). Since fibulin-4 can bind PF2, the
first hybrid motif is probably not essential for binding to N-ter-
minal fibrillin-1 (Fig. 5C), although this motif probably influ-
ences N-terminal fibrillin-1 conformation. Both F4 and nF4
bound PF1 with similar kinetics, implicating the N-terminal
half of fibulin-4 in binding fibrillin-1 (Fig. 5A).
Solid phase binding assays showed that the soluble fibrillin-1
N-terminal fragment PF1 bound strongly to F5 (KD  63  14
nM), and soluble F5 also bound strongly to PF4 and Ex1–11 (Fig.
5B). There was also F5 binding to the deletion fragments Ex3–
11, Ex4–11, Ex5–11, Ex6–11, and Ex5–7 but virtually no F5
binding to Ex7–11 or PF2, neither of which contains the first
hybrid motif (Fig. 5B). Thus, F5 binds to N-terminal fragments
that contain this hybrid motif (Fig. 5C), and there may be a
second binding site N-terminal to Ex5–7. In terms of PF1 bind-
ing site(s) on fibulin-5, four of the fibulin-5 domain pairs (F5-
E12, F5-E45, F5-E56, and F5-E6FC) bound PF1, with the
strongest binding by F5-E6FC and F5-E12 (KD values of
187  31 and 344  54 nM, respectively) (supplemental Fig.
S4B). The interaction with F5-E6FC was partially calcium-de-
pendent (data not shown). Thus, both fibulin-5 N- and C-ter-
minal regions bind N-terminal fibrillin-1. Marfan mutations
(R62C, T101A, and S115C) in the N-terminal region of PF1
significantly reduced binding to F5-E12 and F5-E6FC (Fig.
5D), possibly due to long range conformation effects.
FIGURE 3. Molecular interactions of tropoelastin with fibulin-4 and -5. A, BIAcore analysis of interactions of immobilized tropoelastin with full-length
fibulin-4 (F4) (i) or fibulin-5 (F5, F5C217R, or F5S227P) (ii–iv). These soluble ligands were injected over tropoelastin immobilized on a CM5 chip (see Table 2). Each
sensorgram shows analyte concentrations ranging from 2 to 10 g/ml (for F4) or from 0.4 to 10 g/ml (for F5), with duplicate concentrations included in every
run. One representative experiment is shown. Response difference is the difference between experimental and control flow cells, in response units. Time is
shown in seconds. F4, F5C217R, and F5S227P showed faster dissociation than F5 from tropoelastin. B, solid phase binding curves showing that soluble biotinylated
F4 bound strongly to immobilized tropoelastin but nF4 binding was very weak. One representative experiment is shown. Data are shown with the negative
(biotinylated F4 only) control subtracted. Results are shown as the mean  S.E. of triplicate values. C, solid phase binding assays localizing tropoelastin binding
sites on biotinylated fibulin-5. Three of the domain pair fragments, F5-E12, F5-E45, and F5-E6FC, bound well to immobilized tropoelastin (KD values of 332,
452, and 965 nM, respectively; binding curves are shown in supplemental Fig. S4A), but fragments F5-E23 and F5-E56 interacted only very weakly. One
representative experiment is shown. Data are shown with the negative (biotinylated F5 fragments only) control subtracted. Results are shown as the mean 
S.E. of triplicate values.
TABLE 2
BIAcore surface plasmon resonance analysis of fibulin-4 interactions
with LOX and fibulin-5 interactions with tropoelastin
Surface plasmon resonance bindingwas carried out as described under “Experimen-
tal Procedures.” The kinetics of the evaluation of the interactions was performed
according to a 1:1 binding model. Values are mean  S.E. of at least two separate
experiments.
k
a
k
d
K
D

2
103 M1 s1 10e3 s1 nM
Tropoelastin-F5 44  20 1.3  0.1 64  40 14.8  9.2
Tropoelastin-F5C217R 8.4  2.7 4.6  0.4 865  492 3.3  1.2
Tropoelastin-F5S227P 20  13 9.3  2.3 3423  1439 22.4  13.6
LOX-F4 21.0  0.7 0.7  0.1 33  3 4.6  0.9
LOX-nF4 24.5  8.5 0.4  0.2 14  6 1.1  0.1
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LOX Interacts Strongly with N-terminal Fibrillin-1 and with
Tropoelastin—Using BIAcore, no binding was detected
between immobilized LOX and soluble N-terminal fibrillin-1
(PF1 ligand). However, solid phase assays detected a strong
interaction between soluble LOX and immobilized PF1, with a
KD of 26  11 nM, and at reduced levels to N-terminal deletion
fragments Ex1–11 andEx3–11 (Fig. 6A). However, LOXdid not
bind strongly to any other fibrillin-1 fragments. Thus, we have
demonstrated that LOX interacts strongly and specifically with
N-terminal fibrillin-1, although this interaction is ablated by
LOX immobilization on BIAcore chips.
Using BIAcore, there was no detectable interaction between
soluble LOX and immobilized tropoelastin. However, solid
phase assays detected a strong interaction between LOX and
immobilized tropoelastin, with a KD of 49  11 nM (Fig. 6B).
Thus, LOX binds tropoelastin strongly, although this interac-
tion is ablated by immobilization of tropoelastin on BIAcore
chips.
Defining Fibulin Complexes Using Competitive Inhibition
Binding Assays
Having defined binding interactions of fibulin-4 and -5 with
tropoelastin, LOX, and fibrillin-1 and identified novel interac-
tions between fibulin-4 and -5 and between LOX and N-termi-
nal fibrillin-1, we investigated competition between these inter-
actions in order to gain insights into how these complexes
contribute to elastic fiber formation (for a model, see Fig. 9).
Fibulin-4 Forms a Ternary Complex with LOX and
Tropoelastin—Since theN-terminal half of fibulin-4 binds LOX
strongly (see Table 2 and Fig. 4A), we investigated whether this
interaction regulates binding of fibulin-4 to tropoelastin (Fig. 7,
A and B).
Using BIAcore (see above), F4 bound immobilized tropoelas-
tin with relatively rapid dissociation kinetics, but LOX did not
bind immobilized tropoelastin (Fig. 3A) (data not shown).Here,
BIAcore experiments revealed that F4 binding to immobilized
tropoelastin was markedly enhanced when preincubated with
LOX (equimolar at 200 nM), although binding was partially
inhibited when 200 nM fibulin-4 was preincubated with 1000
nM LOX (Fig. 7A). nF4 did not bind tropoelastin (see Fig. 3B)
even in the presence of LOX (which binds nF4; see Fig. 4A), so
the enhanced binding to tropoelastin in the presence of
equimolar LOXwas not directly LOX-mediated. Fibulin-4may,
by binding LOX, act as a template for tropoelastin, thereby
facilitating its cross-linking by LOX.
Fibulin-5 Does Not Inhibit Fibulin-4 Binding to Tropoelastin—
Although fibulin-4 binds fibulin-5 with moderate affinity (see
Fig. 4C), preincubation of F4 with F5 (both at 100 nM) did not
significantly affect F4 binding to immobilized tropoelastin (not
shown). However, preincubation of F4 with LOX (both at 100
nM) partially inhibited binding of F4 to immobilized F5 (Fig.
7B), so F4-LOX complexes limit association of F4 with immo-
bilized F5. F4-F5 complexes may contribute to elastic fiber for-
mation after elastin cross-linking.
Fibrillin-1 Inhibits Fibulin-4 Binding to LOX and
Tropoelastin—Fibulin-4 (F4 and nF4) binds N-terminal fibril-
lin-1 (PF1) with moderate affinity (see Fig. 5A). In BIAcore
experiments, preincubation of F4 (200 nM) with PF1 (0–3000
nM) inhibited the binding of F4 to immobilized LOX (EC50 365
nM) and to immobilized tropoelastin (EC50 115 nM) (Fig. 7C). A
downstream fibrillin-1 fragment (PF12) that does not bind F4
did not inhibit binding of LOX or tropoelastin to F4 (not
shown). In solid phase assays, preincubation of LOX with PF1
(both at 100 nM; these ligands bind each other strongly; see Fig.
6A) strongly inhibited LOX binding to immobilized F4, nF4, or
tF4 (Fig. 7C). Similarly, solid phase and BIAcore assays showed
that preincubation of F4 and fibrillin-1 (PF1, PF4, or tFib-1, the
C-terminally truncated two-thirds fibrillin-1 fragment) (all at
100 nM) strongly inhibited F4 binding to tropoelastin (Fig. 7C
and supplemental Fig. S4D).
Thus, fibrillin-1 disrupts formation of fibulin-4 interac-
tions with LOX and with tropoelastin. This competition may
enhance deposition of cross-linked elastin globules onto
microfibrils.
Fibrillin-1 Inhibits Fibulin-5 Binding to Tropoelastin—As
shown in binding assays (see Figs. 3A, 4 (B and C), and 5B), F5
strongly binds to tropoelastin and to N-terminal fibrillin-1
(PF1) and moderately binds to F4 but binds weakly to LOX.
Here, BIAcore experiments showed that preincubation of F5
with LOX or F4 did not affect the interaction between F5 and
immobilized tropoelastin (Fig. 7D). However, preincubation
of F5 with PF1 or tFib-1 inhibited F5 binding to tropoelastin
(Fig. 7D).
Although PF1 does not bind tropoelastin, we previously
reported two downstream sites within the N-terminal half of
fibrillin-1 and a third C-terminal fibrillin-1 region that all bind
tropoelastin strongly (see Fig. 5C) (33, 39). El-Hallous et al. (21)
reported that the N-terminal half of fibrillin-1 did not bind
tropoelastin but that fibulin-5 (more than fibulin-4) facilitated
tropoelastin binding to this region of fibrillin-1. Here, we con-
firmed by BIAcore and solid phase assays that a C-terminally
truncated two-thirds fibrillin-1 fragment (tFib-1) binds immo-
bilized tropoelastin (supplemental Fig. S4C) (not shown) and
FIGURE 4. Molecular interactions of LOX with fibulin-4 and -5. A, BIAcore analysis of interactions of immobilized LOX with soluble F4 (i) or nF4 or tF4 (ii)
injected over LOX immobilized on a CM5 chip (see Table 2). In iii, BIAcore interactions of immobilized F4 with soluble LOX, PF1, and F5 are shown (virtually no
interaction was detected with PF2). In i, the sensorgram shows analyte concentrations ranging from 2 to 10 g/ml, with duplicate concentrations included in
every run. One representative experiment in each case is shown. Response difference is the difference between experimental and control flow cells, in response
units. Time is shown in seconds. F4 and nF4 bound strongly to LOX, but tF4 bound weakly. In parallel solid phase assays, F4 was confirmed to bind strongly to
LOX (not shown). B, solid phase binding assays showing soluble biotinylated LOX binding to immobilized F5 (KD  338 nM). One representative experiment is
shown in each case. Data are shown with the negative (biotinylated LOX only) control subtracted. Results are shown as the mean  S.E. of triplicate values.
Soluble biotinylated LOX also bound strongly to four of the fibulin-5 domain pair fragments (F5-E12, F5-E23, F5-E45, and F5-E6FC), but in parallel BIAcore
experiments, there was no detectable binding of full-length fibulin-5 (F5) to LOX (not shown). C, solid phase binding assays showing soluble biotinylated F4
binding to immobilized F5. i and ii, F4 bound strongly to F5, but nF4 shows virtually no binding to F5 (ii). Thus, the binding site for fibulin-5 is in the C-terminal
half of fibulin-4. One representative experiment is shown. Data are shown with the negative (biotinylated F4 or nF4 only) control subtracted. Results are shown
as the mean  S.E. of triplicate values.
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found that fibulin-5 neither inhibited nor stimulated tropoelas-
tin binding to this large fibrillin-1 fragment (not shown).
Hence, fibulin-5 can either bind tropoelastin or fibrillin-1,
probably at the same or an overlapping site. This competi-
tion may facilitate fibulin-5 targeting of tropoelastin onto
microfibrils.
Investigating the Contribution of Fibulin-4 to Elastin
Cross-linking
Recently, Nonaka et al. (45) showed that ARPE-19 cultures
supplemented with tropoelastin form desmosine cross-links,
confirming LOX activity in these cultures and that transfection
with fibulin-5 enhanced cross-links. Here, this culture model
was used, with fibulin-4 siRNA knockdown, to investigate con-
tributions of fibulin-4 to elastin cross-linking.
First, we showed that control ARPE-19 cells expressed mod-
erate levels of fibulin-4 but only low levels of fibulin-5 and that
siRNA of fibulin-4 achieved 70% knockdown (supplemental
Fig. S5A), but fibulin-5 levels remained low (not shown). We
ensured the presence of tropoelastin by transfecting cells with
tropoelastin (supplemental Fig. S5B). Biological duplicate
experiments showed that scrambled tropoelastin-transfected
ARPE-19 cells contained 12.5  3.8 pmol of desmosine/mg of
protein, whereas tropoelastin-transfected fibulin-4 siRNA
knockdown ARPE-19 cells had 15.4  4.3 pmol of desmo-
sine/mg of protein. Increased desmosine was also found in the
knockdown cultures supplemented with 10 g/ml exogenous
human tropoelastin. These data are consistent with increased
desmosine in fibulin-4/ mice (5).
Defining the Contribution of Fibulin-5 to Ordered Elastin
Deposition
The rat fetal lung fibroblast line, RFL6, expresses abun-
dant elastin and deposits elastic fibers (13). In RFL6 cells
with fibulin-5 stably knocked down by shRNA (supplemen-
tal Fig. S5C) but expressing fibulin-4, numerous thick elas-
tin-containing arrays were clearly apparent by light micros-
copy using Miller’s elastin stain (Fig. 8). Transmission
electron microscopy revealed the presence of large elastin
globules and of numerous small, relatively uniform sized
elastin globules with limited association with microfibrils;
these images show similarities with data reported by Choi
FIGURE 5. Molecular interactions of fibrillin-1 with fibulin-4 and -5. A, solid
phase binding assays showing soluble biotinylated F4 binding to immobi-
lized overlapping fragments encompassing full-length fibrillin-1 (i) and to
N-terminal (PF1) deletion and short fragments (ii). F4 bound well to the N-ter-
minal fragments PF1 and PF2 and to several N-terminal deletion fragments
but very weakly to PF4, Ex5–7, and Ex7–11. In iii, binding curves show that
soluble biotinylated F4 bound to immobilized PF1 and PF2. In iv, binding
curves are shown for soluble biotinylated F4 and nF4 binding to immobilized
PF1, indicating that the N-terminal half of fibulin-4 binds N-terminal fibrillin-1.
One representative experiment is shown in each case. Data are shown with
the negative (biotinylated F4 or nF4 only) control subtracted. Results are
shown as the mean  S.E. of triplicate values. B, solid phase binding assays
show soluble biotinylated fibrillin1 (PF1 fragment) binding to immobilized F5
(i) and soluble biotinylated F5 binding to immobilized N-terminal fibrillin-1
fragments (ii). F5 bound well to the N-terminal fragments PF1 and PF4 and to
several N-terminal deletion fragments but weakly to PF2 and Ex7–11. One
representative experiment is shown. Data are shown with the negative (bio-
tinylated F5 only) control subtracted. Results are shown as the mean  S.E. of
triplicate values. C, domain diagram of fibrillin-1 (see Fig. 1 for key), highlight-
ing potential binding sites for F4 and F5, as well as reported binding sites for
tropoelastin (33, 39). D, solid phase assays showing soluble biotinylated fibu-
lin-5 fragments (F5-E12 (i) or F5-E6FC (ii)) binding to immobilized PF1 or to
three different PF1 (Marfan syndrome) mutants (Fig. 1B). Fibulin-5 fragments
bound well to PF1, but binding was significantly reduced to all of these PF1
mutants, especially PF1S115C. Data are shown with the negative (biotinylated
protein only) control subtracted. Results are shown as the mean  S.E. of
triplicate values. Significant differences in binding of each fibulin-5 fragment
to PF1 or to the PF1 mutants are shown as follows: ***, p  0.001 (unpaired t
test). In each case, a representative experiment is shown.
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et al. (30). Hence, fibulin-5 is necessary for deposition of
uniform elastin globules on microfibrils.
Investigating Whether Heparin Influences Fibulin-mediated
Elastic Fiber Formation
Heparan sulfate is abundant at the cell surface as a compo-
nent of syndecan and glypican receptors, and heparan sulfate
interacts with tropoelastin and enhances its coacervation (47–
50). Preincubation of tropoelastin with heparin (10 and 100 nM)
caused significant but limited reduction in binding of fibulin-4
and -5 to tropoelastin (supplemental Fig. S6A). Preincubation
of fibulin-5 domain pair fragments F5-E12, F5-E45, and
F5-E6FC (which bind tropoelastin; see Fig. 3C; supplemental
Fig. 4A) with heparin also significantly inhibited their ability to
interact with tropoelastin (supplemental Fig. S6B). Heparin
also partially inhibited F5-E6FC binding to PF1 but enhanced
the interaction of F5-E12 with PF1 (not shown). Thus, cell
surface heparan sulfate subtly influences fibulin-mediated elas-
tic fiber interactions.
DISCUSSION
Elastic fiber formation is a complex multistage process that
proceeds through the formation of cross-linked elastin globules
and their deposition on microfibrils, where they coalesce to
FIGURE 6. Molecular interactions of LOX with fibrillin-1 and tropoelastin. A, solid phase binding assays showing soluble biotinylated LOX binding to
immobilized fibrillin-1. i and ii, LOX binds to the N-terminal fibrillin-1 fragment PF1 and shows reduced binding to PF1 deletion fragments but no binding to
Ex5–7. iii, binding curve showing soluble biotinylated LOX binding to immobilized PF1. One representative experiment is shown. Data are shown with the
negative (biotinylated LOX only) control subtracted. Results are shown as the mean  S.E. of triplicate values. B, solid phase binding curve showing soluble
biotinylated LOX binding to immobilized tropoelastin. One representative experiment is shown. Data are shown with the negative (biotinylated LOX only)
control subtracted. Results are shown as the mean  S.E. of triplicate values.
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form fibers (19, 20). Knock-outmice revealed that fibulin-4 and
-5 have essential non-compensatory roles in this process (5–7),
but their roles in this process remain unresolved. To gain
insights into their distinct contributions, we delineated how
they interact withmajor elastic fibermolecules (with tropoelas-
tin; with LOX, which cross-links tropoelastin; and with fibril-
lin-1, which forms themicrofibril template) and have identified
novel fibulin-fibulin interactions and fibulin interactions with
LOX and fibrillin-1. The first stage of elastin deposition is envi-
sioned to involve the pericellular assembly of elastin into glob-
ules and their stabilization through cross-linking by LOX; our
data show that fibulin-4 strongly binds LOX, and this interac-
tion enhances formation of a ternary complex that can regulate
elastin cross-linking (Fig. 9). The second stage of elastin depo-
sition encompasses deposition of elastin globules on microfi-
brils and their accretion to form a fiber; our data show that
fibulin-5 can interact with tropoelastin or with fibrillin-1,
implying a chaperone role for fibulin-5 in directing elastin onto
microfibrils (Fig. 9).
MALLS analysis of fibulin-4 revealed that it can form dimers
in the presence of calcium. This property may reside within the
N-terminal half of the molecule, since an N-terminal fragment
(nF4) also underwent calcium-dependent dimerization, which
suggests parallel dimers. Within the extracellular matrix, fibu-
lin-4 is exposed to low millimolar calcium and may be dimeric;
all binding assays were therefore conducted in the presence of
calcium. The analysis of fibulin-4 by rotary shadowing elec-
tronmicroscopy has indicated a short rodlike structure with a
globular end-domain (4, 51). Here, single-particle averaging
electron microscopy of negatively stained fibulin-4, which pro-
vides enhanced molecular details, reveals a bent rodlike struc-
FIGURE 7. Molecular interactions and competition assays. A, analysis of the
effect of LOX on soluble F4 interacting with immobilized tropoelastin. In BIA-
core experiments, F4 was soluble ligand alone or preincubated with LOX. F4
binding to tropoelastin was enhanced following preincubation of F4 with
LOX (both at 200 nM) but reduced following F4 preincubation with 1000 nM
LOX. (LOX does not bind immobilized tropoelastin; not shown.) One repre-
sentative experiment is shown. Response difference is the difference
between experimental and control flow cells, in response units. Time is shown
in seconds. B, solid phase binding assay showing that preincubation of solu-
ble biotinylated F4 with LOX (both at 100 nM) partially inhibited the interac-
tion of F4 with immobilized F5. A significant difference in binding of F4 pre-
incubated with LOX to F5 was shown as follows: **, p  0.01 (unpaired t test).
One representative experiment is shown. Data are shown with the negative
(biotinylated protein only) control subtracted. Results are shown as the
mean  S.E. of triplicate values. C, analysis of the effect of PF1 on soluble F4
interacting with immobilized LOX or tropoelastin. In BIAcore experiments (i
and ii), F4 was a soluble ligand, alone or preincubated with increasing con-
centrations of PF1 (Log10 Conc PF1). F4 binding to LOX (i) and to tropoelastin
(ii) was inhibited by PF1, with EC50 values of 365 and 115 nM, respectively. In
each case, one representative experiment is shown. Response difference is
the difference between experimental and control flow cells, in response units.
iii, solid phase binding assays confirmed both that soluble biotinylated LOX
(100 nM) interacted with immobilized F4 and nF4 but more weakly with tF4
and that preincubation of LOX with PF1 (100 nM) strongly inhibited all of these
interactions. Significant differences in binding of LOX preincubated with PF1
to F4, nF4, or tF4 were shown as follows: ***, p  0.001 (unpaired t test).
iv, solid phase binding assays confirmed both that soluble biotinylated F4
(100 nM) interacted with immobilized tropoelastin and that preincubation of
soluble F4 with PF1 or PF4 (all at 100 nM) strongly inhibited this interaction.
Significant differences in binding of F4 or F4 preincubated with PF1 to tro-
poelastin were shown as follow: ***, p  0.001 (unpaired t test). In each case,
one representative experiment is shown. Data are shown with the negative
(biotinylated protein only) control subtracted. Results are shown as the
mean  S.E. of triplicate values. BIAcore analysis of soluble F4 interacting with
immobilized tropoelastin confirmed that preincubation of F4 with tFib-1 (a
C-terminally truncated two-thirds fragment of fibrillin-1) markedly inhibits F4
binding to tropoelastin (see supplemental Fig. S4D). D, BIAcore analysis of
soluble F5 interacting with immobilized tropoelastin. In i, F5 was soluble
ligand alone, or preincubated with either LOX or F4 or with the fibrillin-1
fragments PF1 or tFib-1 (all at 200 nM). The ability of F5 to bind tropoelastin
was unaffected by preincubation with LOX or F4 but was inhibited by PF1
(which does not contain tropoelastin binding sites) and inhibited more
strongly by tFib-1 (which contains tropoelastin binding sites; see Fig. 4D).
ii, increasing concentrations of soluble PF1 (Log10 Conc PF1) inhibited bind-
ing of F5 to tropoelastin. In each case, one representative experiment is
shown. Response difference is the difference between experimental and con-
trol flow cells, in response units.
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ture. It is unclear whether the globular end-domain is the N or
C terminus.
The absence of fibulin-4 causes a much more severe peri-
natal-lethal elastic fiber phenotype than loss of fibulin-5, and
the drastic reduction in desmosine and concomitant appear-
ance of rodlike structures likely to contain glycosaminogly-
cans (26) indicates a critical regu-
latory role in elastin cross-linking
(5). We have identified a high
affinity LOX binding site within
the N-terminal half of fibulin-4
and shown that fibulin-4 binding
to LOX enhances tropoelastin
binding and ternary complex for-
mation. Reduction of fibulin-4 on
a background of low fibulin-5
enhanced LOX-mediated elastin
cross-linking, which is similar to
that in fibulin-4/ mice, which
showed 20% increase in desmo-
sine (5). The fibulin-4/fibulin-5
ratio may be critical, since Nonaka
et al. (45), using the same cell sys-
tem, showed increased desmo-
sines when cells were transfected
with fibulin-5. The novel interac-
tion between fibulin-4 and -5 that
we have described here may con-
tribute after initial elastin cross-
linking but is unlikely to be essen-
tial for cross-linking, since LOX
partially inhibited this interaction,
whereas mice with no fibulin-5
have only 16% reduction in des-
mosine cross-links (7). With low
levels of fibulin-4 and -5, elastin
probably forms larger globules
that may be rapidly cross-linked.
Overall, these data confirm that
fibulin-4 plays a central regulator
role in cross-linking, probably by
acting as a template to control
LOX activation and to juxtapose it
with tropoelastin. Consequent
lysine-derived cross-link forma-
tion will displace glycosaminogly-
cans and allow normal elastin
assembly. Although LOX and tro-
poelastin can both bind fibrillin-1,
microfibrils are insufficient to
support elastin cross-linking in
fibulin-4 null mice. Depletion of
fibulin-4 may enhance free LOX,
which could alter cell behavior by
oxidizing cell surface proteins,
such as platelet-derived growth
factor receptors, (52).
We and others have reported
that fibulin-4 and -5 bind N-terminal fibrillin-1 (21, 22, 53)
and microfibrils (22). Here, we show exquisite differential
features to the binding of both fibulins to fibrillin-1, since
fibulin-4 can bind fibrillin-1 in the presence or absence of
the first hybrid motif, whereas fibulin-5 binds fragments that
contain this motif. These Marfan mutations in N-terminal
FIGURE 8. shRNA knockdown of fibulin-5 in RFL6 cells. i, Miller’s elastin staining of RFL6 scrambled
control (Scr) and fibulin-5 shRNA knockdown (F5 kd) cultures (8 and 12 days); this stain highlights elastin
as dark deposits. The scrambled control cultures contained a dense network of elastin, whereas the F5
knockdown cells formed prominent thick elastin arrays. Scale bars, 250 m. ii, immunofluorescence
microscopy of RFL6 scrambled control and fibulin-5 shRNA knockdown cultures (4 and 8 days; 4d and 8d,
respectively), using elastin RA75 polyclonal antibody (red) and cell nuclear staining (4,6-diamidino-2-
phenylindole; blue). By 8 days, the fibulin-5 knockdown cultures showed more prominent staining of
elastin than the scrambled control cultures. Scale bars, 50 m. iii, transmission electron microscopy of
RFL6 scrambled control and fibulin-5 shRNA knockdown cultures at 10 days. In the scrambled control
cultures, elastin was accreting within microfibril bundles, whereas in the fibulin-5 knockdown cells, small
elastin globules (indicated by an asterisk) formed large aggregates that were mainly distinct from micro-
fibrils. MF, microfibrils; E, elastin. Scale bars, 1.4 m.
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fibrillin-1 that reduce binding to F5-E12 and F5-E6FC
imply long range conformation effects. Fibrillin-1 competes
with LOX and tropoelastin to bind fibulin-4, perhaps com-
peting for the same site on fibulin-4, so the fibulin-
4LOXtropoelastin complex may be important before elas-
tin deposition on microfibrils. Although N-terminal
fibrillin-1 is known to be a “sticky” sequence, its specific
interactions shown here with LOX, fibulin-5, and tropoelas-
tin highlight its central role in regulating elastin deposition
on microfibrils.
Tissue-purified LOX was reported to cross-link recombi-
nant tropoelastin in the absence of other molecules (54) and
bound to the C-terminal half of
tropoelastin by ligand blot overlay
assay (46). Here, using BIAcore,
repeated attempts failed to detect
any direct binding of LOX to
immobilized tropoelastin or of
fibrillin-1 to immobilized LOX.
However, using solid phase assays,
strong interactions were detected
between LOX and immobilized
tropoelastin and between LOX
and immobilized fibrillin-1. Clear-
ly, immobilization of tropoelastin
and LOX onto CM5 chips impedes
these interactions. Molecules are
generally covalently coupled to
these chips via amines (often lysyl),
as well as thiol, aldehyde, or car-
boxyl groups. It is thus important to
confirmBIAcore data by solid phase
assays.
Elastic fiber formation may pro-
ceed by the deposition and ordered
accretion of elastin globules on
microfibrils (18–20). Here, deple-
tion of fibulin-5 caused the appear-
ance of elastin-rich thick fibrous
structures, as seen by light micros-
copy, and of numerous small elastin
globules accreted into large aggre-
gates adjacent to microfibril bun-
dles, as seen by electron micros-
copy. Thus, fibulin-5must normally
facilitate deposition of uniformelas-
tin globules onto microfibrils and
prevent uncontrolled aggregation.
These findings are consistent with a
study of fibulin-5 null mice dermis
in which elastin globules were adja-
cent to but not integrated within
microfibril arrays (30). Although
fibulin-4 and LOX can both bind
fibrillin-1, they do not efficiently
target elastin onto microfibrils or
prevent aberrant elastin aggrega-
tion when fibulin-5 is depleted. Our
data showing that fibrillin-1 and tropoelastin compete to bind
fibulin-5 are consistentwith fibulin-5 chaperoning cross-linked
elastin globules onto microfibrils, where they may then be sta-
bilized by elastin interactions with fibrillin-1 (Fig. 9). It seems
unlikely that fibulin-5 facilitates deposition of individual tro-
poelastin monomers onto microfibrils, since oxidation by LOX
precedes elastin deposition on microfibrils (20), whereas we
have shown that fibrillin-1 inhibits the ternary complexes of
fibulin-4, LOX, and tropoelastin that may facilitate cross-link-
ing. In summary, our study providesmolecular explanations for
the non-overlapping essential roles of fibulin-4 and -5 in elastic
fiber formation.
FIGURE 9. Modeling elastic fiber interactions of fibulin-4 and -5. A, schematic diagram showing the elastic
fiber interactions of fibulin-4 and -5. Thick black lines represent strong interactions, and thinner black lines show
weaker interactions. Red lines indicate how fibrillin-1 binding to fibulins inhibits their interactions with LOX and
tropoelastin. The blue oval highlights the ternary complex between fibulin-4, LOX, and tropoelastin, and the
yellow oval highlights the complex between fibulin-5 and tropoelastin. TE, tropoelastin; Fib-1, fibrillin-1; F4,
fibulin-4; F5, fibulin-5. B, schematic model indicating how fibulin interactions may contribute to elastic fiber
assembly. Our binding data indicate that fibulin-4-LOX interactions facilitate formation of ternary complexes
with tropoelastin; these complexes may regulate LOX activation and elastin cross-linking. Following fibulin-5
depletion, elastin appears aggregated and distinct from microfibrils, so fibulin-5 must normally regulate elastin
globules and direct their interaction with microfibrils, either by first associating with microfibrils and then
attracting elastin globules to bind microfibrils or by first associating with elastin globules and then facilitating
their deposition on microfibrils. Our data support the latter model. Once localized at microfibrils, elastin prob-
ably interacts directly with fibrillin-1, since these interactions can be high affinity (39), and fibulin-5 interactions
with fibrillin-1 and tropoelastin are mutually inhibitory. Active LOX may remain associated with and cross-link
coalescing elastin globules on microfibrils. Fibulin-4 and -5 may remain associated with microfibrils or may
“recycle” for further elastin deposition.
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LEGENDS TO SUPPLEMENTARY FIGURES 
 
FIGURE S1 
SDS-PAGE analysis of recombinant fibulins -4 and -5, fibrillin-1 and LOX 
The following proteins were expressed and analyzed by SDS-PAGE in the presence or absence of 
10 mM dithiothreitol (R or NR, respectively), by Coomassie blue staining: full-length fibulin-4 
(F4), C-terminally truncated fibulin-4 (tF4), the N-terminal half of fibulin-4 (nF4) and the five 
central cbEGFs (eF4); full-length fibulin-5 (F5) without or with two cutis laxa mutations (F5C217R 
and F5S227P), and domain pair fragments; fibrillin-1 fragments have previously been reported (not 
shown) (1-8) apart from  a two-thirds fragment (tFib-1) which is shown by western blotting as a 
250 kDa fragment using several anti-fibrillin-1 antibodies including (shown) fibrillin-1-specific RGD 
antibody (9); full-length lysyl oxidase (LOX). Treatment of F4 and tF4 with N-glycosidase F 
(PNGase F; indicated by arrows) resulted in slightly faster electrophoretic migration, indicating 
that both are N-glycosylated. Treatment of F5 and mutants, F5-E4+5, F5-E5+6 and F5-E6FC 
with N-glycosidase F also confirmed that they were N-glycosylated (not shown) (1,3). Fibrillin-1 
fragments have been confirmed to be N-glycosylated.  
 
FIGURE S2 
Mass spectrometry of truncated fibulin-4 and fibrillin-1 
(A) The peptide sequence coverage (shown in red text), as determined by mass spectrometry, of 
F4 and tF4. Truncated fibulin-4 tF4 lacks the FC domain and 6 preceding amino acid residues 
(for domain organization, see Fig. 1A). 
(B) The peptide sequence coverage (shown in red text), as determined by mass spectrometry, of 
the two-thirds truncated fibrillin-1 fragment (tFib-1) (for domain organization, see Fig. 1B).  
 
FIGURE S3 
Multi-angle laser light scattering of human fibulins -4 and -5 
Monomers of (i) fibulin-4 (F4) and (ii,iii) fibulin-5 (F5 and F5S227P) that had been isolated by 
Superdex 200 gel filtration in HBS, were analyzed by MALLS in HBS. Samples eluting from the 
column passed through a Wyatt EOS 18-angle light scattering detector fitted with a 688 nm laser 
and an Optilab r-EX refractometer (see Table 1). F4 was monomeric in the absence of calcium, 
but formed dimers in the presence of calcium. Similarly, F5 and F5 mutant F5S227P were 
 2
monomeric in the absence of calcium, but dimeric in the presence of calcium (not shown; Jones 
et al, in preparation).  
 
FIGURE  S4 
Molecular interactions of fibulin-5, fibrillin-1 and tropoelastin 
(A) Solid-phase assays of biotinylated fibulin-5 fragments binding to immobilized tropoelastin. 
Three of the domain pair fragments, F5-E1+2, F5-E4+5 and F5-E6FC bound well to immobilized 
tropoelastin (KDs 332 nM, 452 nM and 965 nM, respectively). One representative experiment is 
shown. Data are shown with the negative (biotinylated F5 fragments only) control subtracted.  
Results are shown as the mean ± S.E. of triplicate values. 
(B) Solid-phase curves showing soluble biotinylated fibulin-5 domain-pair fragments (F5-E1+2 
or F5-E6FC) binding to immobilized PF1. These fibulin-5 fragments only bound N-terminal 
fibrillin-1. One representative experiment is shown. Data are shown with the negative 
(biotinylated F5 fragments only) control subtracted. Results are shown as the mean ± S.E. of 
triplicate values. 
(C) BIAcore analysis of soluble tFib-1 (200 nM) (C-terminally truncated two-thirds fragment of 
fibrillin-1; see Figure S1)) binding to immobilized tropoelastin. Response difference is the 
difference between experimental and control flow cells, in response units (RU). Pre-incubation of 
F5 with tFib-1 neither inhibited nor stimulated the binding of fibrillin-1 to tropoelastin (not 
shown).  
(D) Fibrillin-1 (tFib-1) inhibits soluble F4 interacting with immobilized tropoelastin. BIAcore 
analysis of the interaction of soluble F4 with immobilized tropoelastin, showing that pre-
incubation of F4 with tFib-1 (C-terminally truncated two-thirds fragment of fibrillin-1; see Figure 
S1) inhibits F4 binding to tropoelastin.  
 
 
FIGURE S5 
Elastic fiber molecules expressed by dermal fibroblasts, ARPE-19 cells and RFL6 cells 
(A) (i) RT-PCR analysis of the expression of fibulins -4 and -5 by ARPE-19 cells. Fibulin-4 was 
expressed at moderate levels, but fibulin-5 expression was very low. (ii) Fibulin-4 was knocked 
down in ARPE-19 cells using siRNA. Quantitative PCR (qPCR) and immunoblot analysis (not 
shown) showed 70% knockdown of fibulin-4. 
(B) The expression of N-terminally V5-tagged human elastin (E) by ARPE-19 cells, after 
retroviral induction, was detected on blots by anti-V5 antibody (Abcam) and by 
immmunofluorescence microscopy (red) using a polyclonal anti-elastin antibody (PR398, Elastin 
Products Inc.), with DAPI (blue) staining of cell nuclei.  
(C) Fibulin-5 was stably knocked down in RFL6 cells by retroviral shRNA. (i) RT-PCR and (ii, 
iii) qPCR, respectively, showed that fibulin-5 is depleted in the knockdown cells, compared to 
the scrambled control cells. qPCR also revealed that fibulin-4 is not altered in the fibulin-5 
shRNA knockdown cells (not shown).  
 
 
FIGURE S6 
Effects of heparin on tropoelastin binding by fibulins -4 and -5 
Heparin binds tropoelastin and influences its coacervation (Tu and Weiss, 2008). We examined 
whether heparin altered interactions of fibulins -4 and -5 with tropoelastin, by solid phase assays.  
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(A) (i) Pre-incubation of fibulins -4 or -5 with 10 nM or 100 nM heparin resulted in small but 
significant reductions in each fibulin binding to tropoelastin. A significant difference in binding 
of F4 or F5 to tropoelastin in the presence or absence of heparin was shown as ***, p < 0.001 
(unpaired t test). (ii) Increasing concentrations of heparin inhibited fibulin-4 binding to 
tropoelastin, but concentration-dependent heparin effects on fibulin-5 binding were less clear.  In 
each case, one representative experiment is shown. Data are shown with the negative 
(biotinylated F4 or F5 only) control subtracted. Results are shown as the mean ± S.E. of triplicate 
values. 
(B) Pre-incubation of three fibulin-5 domain pair fragments that bind tropoelastin (see Fig. 2C) 
with heparin (both at 100 nM) resulted in significant reductions in fibulin binding to tropoelastin. 
Significant differences in binding of fibulin-5 domain pair fragments to tropoelastin in the 
presence or absence of heparin were shown as *, p<0.01; **, p < 0.05; ***, p < 0.001 (unpaired t 
test). In each case, one representative experiment is shown. Data are shown with the negative 
(biotinylated F5 fragments only) control subtracted. Results are shown as the mean ± S.E. of 
triplicate values. 
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